Concepedia

Publication | Open Access

Adalimumab biosimilars in the therapy of Crohn´s disease and ulcerative colitis: Prospective multicentric clinical monitoring

10

Citations

30

References

2022

Year

Abstract

This prospective observational study proved the effectiveness of the adalimumab biosimilars FKB327 and GP2017 in IBD.

References

YearCitations

Page 1